Last edition
News about "BDBV vaccine candidate"
Uganda Launches Phase I Trial of Bundibugyo Ebola Vaccine
Uganda has launched a Phase I trial of Oxford’s Bundibugyo Ebola vaccine candidate, with Serum Institute of India supplying investigational doses to support clinical evaluation and global epidemic preparedness.
BDBV Vaccine Candidate | 14/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members